Novalon Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 1
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Novalon General Information

Description

Developer of therapeutic drugs. The company's therapeutic drugs comprises of complex generics products that are difficult to develop and produce, enabling pharmaceutical companies to develop rare drugs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • Rue Saint-Georges 5
  • 4000 Liège
  • Belgium
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novalon Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novalon‘s full profile, request access.

Request a free trial

Novalon Executive Team (1)

Name Title Board Seat Contact Info
François Fornieri Founder
To view Novalon’s complete executive team members history, request access »

Novalon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial